Asia
Initiative highlights commitment to the highest health and safety standards in the workplace in cooperation with the American Hospital in Dubai
Facility is acquired from Porton Pharma Solutions Ltd., and operated with GMP compliance.
Gamida Cell Ltd. filed for a $69 million initial public offering for the Nasdaq exchange, according to a filing submitted last week to the U.S. Securities and Exchange Commission, Israel’s Calcalist first reported last week.
Singapore scientists’ discovery could hold the key to novel treatments for the symptoms of mosquito-borne diseases
Portfolio of Products, Education and Training to Help Surgeons Handle Challenging Reoperations
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Eli Lilly just signed a license deal with Tokyo’s Chugai Pharmaceutical Co. for OWL833, Chugai’s oral non-peptidic GLP-1 receptor agonist. It is Phase 1-ready being evaluated for type 2 diabetes.
Ground-breaking technology unlocks rapid and simple label-free 3D and 4D live cell imaging
As the acquisition of Dublin-based Shire by Japan-based Takeda Pharmaceutical edges forward, yet another major Takeda shareholder has spoken out in opposition to the deal.
Aridis Pharmaceuticals, headquartered in San Jose, California, announced it had added broad patent coverage of two of its product candidate monoclonal antibodies.
PRESS RELEASES